CUL2 and neoplasm: VHL is a tumor suppressor, acting as a substrate adaptor, consisting of the VHL E3 ubiquitin ligase complex together with Cullin-2 (Cul-2), Elongins B/C (ELB/ELC), and RING-box (Kaelin, 2002).